{"id":"W3134569209","doi":"10.1182/blood.2020009806","title":"Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1","year":2021,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Oncology; Anaplastic large-cell lymphoma; Chemotherapy; Chemotherapy regimen; Anaplastic lymphoma kinase; Lymphoma; Hodgkin lymphoma; Lung cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001505712,0.0004031303,0.0009837759,0.0002311335,0.0001796148,0.0004320485,0.0003550517,0.0003811812,0.0004840929],"category_scores_gemma":[0.001019904,0.0001578776,0.0006750579,0.000319158,0.0002901617,0.0003895955,0.0001964273,0.001306835,0.0001165482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008291775,"about_ca_system_score_gemma":0.0008535002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009997721,"about_ca_topic_score_gemma":0.002797708,"domain_scores_codex":[0.9995891,0.000243776,0.00003154334,0.0000343094,0.0000586534,0.00004259811],"domain_scores_gemma":[0.9993675,0.0001725853,0.0001435426,0.00004012677,0.00005081761,0.0002253684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2618915,0.01581774,0.1000735,0.001117242,0.002706577,0.001101752,0.000600907,0.007584935,0.02210524,0.0006545311,0.01065952,0.5756865],"study_design_scores_gemma":[0.2206379,0.4335374,0.2820297,0.0005032388,0.003360595,0.003689172,0.0002337266,0.007705603,0.01219503,0.0006589468,0.03536121,0.00008740048],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891229,0.008252396,0.0003063921,0.0004777517,0.00004582588,0.000191047,0.0003955748,0.00002940199,0.001178604],"genre_scores_gemma":[0.9880818,0.006891297,0.00160024,0.0006679357,0.0001198718,0.0002595296,0.001714325,0.00002434641,0.0006406113],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001505712,"threshold_uncertainty_score":0.007963121,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008790326467041958,"score_gpt":0.2373149541415631,"score_spread":0.2285246276745211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}